fingolimod hydrochloride has been researched along with Polyneuropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erdem-Özdamar, S; Erdener, ŞE; Göçmen, R; Kurne, A; Nurlu, G | 1 |
| Bae, H; Dukala, D; Jung, CG; Kakazu, R; Kim, HJ; Soliven, B; Wollmann, R | 1 |
| Chabwine, JN; Démonet, JF; du Pasquier, RA; Hirt, L; Kuntzer, T; Michel, P; Rossetti, AR; Schluep, M; Vingerhoets, FG | 1 |
3 other study(ies) available for fingolimod hydrochloride and Polyneuropathies
| Article | Year |
|---|---|
Remission with fingolimod in a case of demyelinating polyneuropathy.
Topics: Adolescent; Demyelinating Diseases; Electric Stimulation; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Neural Conduction; Polyneuropathies; Propylene Glycols; Sphingosine | 2014 |
Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy.
Topics: Animals; Autoimmunity; Blood-Nerve Barrier; Blotting, Western; Cell Culture Techniques; Cell Proliferation; Cell Survival; Cytokines; Electrophysiology; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Mice; Mice, Inbred NOD; Mice, Transgenic; Oxadiazoles; Polymerase Chain Reaction; Polyneuropathies; Propylene Glycols; Schwann Cells; Severity of Illness Index; Sphingosine; Spleen; Thiophenes | 2009 |
[Neurology].
Topics: Antibodies, Monoclonal; Anticonvulsants; Atrial Fibrillation; Carbamates; Chronic Disease; Deep Brain Stimulation; Dopamine Agonists; Epilepsy; Fingolimod Hydrochloride; Genetic Therapy; Humans; Immunosuppressive Agents; Ischemic Attack, Transient; Multiple Sclerosis; Muscular Diseases; Neurology; Parkinson Disease; Phenylenediamines; Polyneuropathies; Propylene Glycols; Sphingosine; Stroke; Treatment Outcome; Valproic Acid | 2012 |